Hedge fund managers sit on the boards of Bausch Health and Bausch + Lomb. They don’t think like your typical corporate board, ...

Bausch Health is rumored to be looking to sell its Bausch + Lomb business, which will ease bankruptcy concerns and upgrade ...

PhRMA has tried to distance its R&D-based members from opportunistic firms like Valeant and Martin ... calling for an end to tax credits for pharmaceutical advertising, and also suggests curbs ...

As the largest beauty product maker globally ... and Ambi in 2017 from Canadian firm Valeant Pharmaceuticals. While the purchase price was high at 7.7 times sales, we believe L’Oreal has ...

The first instalment of two-part article looking at people behind the most important events and trends in pharma, biotech and wider world of healthcare in 2015. The year saw a flurry of innovative ...

The most important intervention in ASCVD is prevention, which includes promoting a healthy diet based on products ... Freia Pharmaceuticals, Novartis, Novo-Nordisk, Polfarmex, Sanofi-Aventis; Grants ...

By David Gelles Valeant Pharmaceuticals is planning to team up with William Ackman in hopes that an increased offer will be enough to end a bidding war for Salix Pharmaceuticals. The company is ...

EMC Pharma leverages its global network of developers and manufacturing partners to create an expanding portfolio of pharmaceutical products commercialized for the US market. Further information ...